| Gene Set | Leading Edge Genes |
|---|
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | NOLC1, SLC39A14, PMAIP1, PBK, ASNS, C1ORF163, CALU, TIPRL, EIF2S1, HSPA14, P4HA1, CKS1B, DERL1, EIF4EBP1, GMPS, CDC6, TNFRSF12A, TIPIN, DIAPH3, YME1L1, HSPA4, MPHOSPH10, TNFRSF10B, BOLA2 /// BOLA2B, SPCS3, MRPS16, ARSB, MED6, CLIC4, NUP155, MTHFD2, CSE1L, ZWILCH, PDCD5, AGPS, DNMT1, FAF1, DTL, C12ORF48, ME2, EIF2S3, CYP51A1, CFI, C18ORF10, DNAJC9, CDKN2B, MATR3, CARS, RSRC1, SSX2IP, RAD51C, PHLDA2, COPS8, DBF4, EIF2S2, USP47, ADSL, TOPBP1, CENPF, MRPL42, WDR41, MICAL2, FEN1, C7ORF44, TPR, TFRC, GDI2, CKS2, HCCS, TTC26, SGCB, TOMM22, ITGB3BP, ACTR2, TRIP11, PSPH, AK3L1, NPM3, PPAT |
| MITSIADES RESPONSE TO APLIDIN DN | SEPT9, NCAPD2, RRM2, GNB1, RSRC1, ANKRD10, NUCKS1, EIF2AK2, CENPA, CSE1L, TOP2A, SNRPA, CENPF, DDAH1, DERL1, TPR, GMPS, TPX2, RAP2A, MCM5, WEE1, TBL1X, KIAA0100, C18ORF10, TIPIN, EIF4B, PPAT, BIRC5 |
| SCHLOSSER MYC TARGETS REPRESSED BY SERUM | POLE3, NOLC1, ACVR1B, KIAA0020, MTHFD2, SERP1, PWP1, MRPL3, APP, EIF4E, HSPE1, SNRPF, PRPS1, UBE2N, EIF2S1, FBXO21, EXOSC8, SSB, SFRS1, CCT5, NUP93, NDUFB6, SARS, PMPCB, DCTD, CSDA, ANP32B, U2AF1, IARS |
| DANG MYC TARGETS UP | RPL10, RPL27, LTA4H, HSPD1, RPS17, NUP155, SNRPD3, RPS5, RPS16, SHMT1, HSPE1, EIF4E, LDHA, EIF2S1, RPL27A, RPS19, DBI, EXOSC8, TFRC, RPL19, RPL9, RPS13, CCT5, SFRS7, RPL5, CKS2, GAPDH, PTMA, NPM1, RPL3 |
| TIEN INTESTINE PROBIOTICS 6HR UP | RPS11, ACTB, RPL23A, UBC, RPS17, RPS3A, PPIA, RPS6, RPS14, TPT1, RPLP0, RPL23, HMGB1, RPS23, RPS19, RPL27A, FTL, C6ORF62, EEF1A1, RPS7, RPL9, RPS2, RPL39, RPL5, GAPDH, EIF4B, RPS27, RPS24, RPL41, HSPA1A /// HSPA1B |
| SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP | CDKN3, KIF20A, ORMDL2, C3ORF37, RRM2, ZWINT, CENPA, PDSS1, TXN, POLR2K, EXO1, SNRPF, TOP2A, CENPF, COX7B, FEN1, GMPS, CKS2, MCM6, HIST1H4B, HCCS, BOLA2 /// BOLA2B, SPAG5, RFC4, NUTF2, OIP5, UBE2N, PSMA7, CCNB2, C12ORF48, TPX2, NUDT1, PFDN6, CCT5, NUP93, DNAJC9, H2AFV, BIRC5 |
| WINNEPENNINCKX MELANOMA METASTASIS UP | CDKN3, HTRA2, RRM2, HSPD1, RSRC1, ZWINT, MRPS16, SPAG5, CENPA, GINS2, PWP1, RFC4, EXO1, RFC5, TOP2A, CENPF, TYMS, CKS1B, C12ORF48, CCNB2, DCBLD2, GMPS, NCBP1, CDC6, CCT5, CKS2, H2AFV, CCT4, BIRC5, HSPA4 |
| WHITEFORD PEDIATRIC CANCER MARKERS | CKS1B, CCNB2, EIF4EBP1, RRM2, NUDT1, MCM5, SOX4, CENPA, CKS2, TOP2A, CCNT1, DNMT1, CENPF, BIRC5 |
| LUI THYROID CANCER CLUSTER 3 | PSMD8, RPS2, SARS, RPS5, FBL, RPL18, RPL10A, RPL17 |
| AKL HTLV1 INFECTION UP | APP, SQRDL, AP2B1, S100A10, SOX4, DNAJC7 |
| MONTERO THYROID CANCER POOR SURVIVAL UP | |
| BIOCARTA EIF PATHWAY | |
| ODONNELL TARGETS OF MYC AND TFRC DN | |
| CHNG MULTIPLE MYELOMA HYPERPLOID UP | RPL35, RPL24, RPLP1, RPS17, RPS6, RPS16, RPL18, RPS9, RPS23, RPL27A, RPS19, UBA52, RPS13, RPL14, RPL15, RPL28, RPL37, FBL, RPL13A, RPS15, NPM1 |
| MODY HIPPOCAMPUS PRENATAL | |
| KANG DOXORUBICIN RESISTANCE DN | |
| BIOCARTA EIF2 PATHWAY | |
| NCI REGULATION OF THE FANCONI ANEMIA PATHWAY | |